Insulinoma

Insulinoma is a rare tumor that arises from the beta cells of the pancreas, which are responsible for producing insulin. This formation leads to hyperglycemia due to excessive insulin production, which in turn causes severe hypoglycemic conditions in patients. Insulinoma is benign in most cases, but in rare cases it can be malignant. The main manifestations of the disease include hypoglycemia attacks that can occur suddenly and be accompanied by sweating, palpitations, tremors, and changes in consciousness up to loss of consciousness. Diagnosis and treatment of insulinoma require an individual approach and highly qualified specialists.

History of the disease and interesting historical facts

Insulinoma was first described in 1929, when the medical community began to understand the role of insulin in regulating blood glucose levels. Major research in this area was conducted in the 1930s and 1940s. In the 1940s, it was discovered that insulinoma could cause serious complications, including hypoglycemic coma and even death if not treated properly. Over time, the development of imaging techniques and modern laboratory tests have improved the diagnosis of this disease. Today, insulinoma is considered one of the best-studied endocrine tumors, which has reduced morbidity and mortality compared to previous decades.

Epidemiology

Insulinoma is a rare tumor, with an incidence of approximately 1-4 cases per 100,000 people per year. Statistically, this type of tumor is more common in patients aged 40-60 years, although it can also be observed in younger patients. Approximately 10-30% of all insulinoma cases are hereditary and are associated with syndromes such as multiple endocrine neoplasia type 1 (MEN 1). In addition, insulinoma may be associated with other factors, such as beta-cell hyperplasia, which also increases the risk of its occurrence.

Genetic predisposition to this disease

Several genes have been identified to date that may be involved in the development of insulinoma. The main ones are the MEN1, AKT2 genes, as well as genes responsible for the regulation of the cell cycle and apoptosis. Mutations in the MEN1 gene lead to the development of multiple endocrine neoplasia, which may include insulinoma as one of its components. It is important to note that most cases of insulinoma are sporadic and are not associated with a clear hereditary predisposition. However, a family history may signal a higher risk.

Risk factors for the development of this disease

Risk factors that contribute to the development of insulinoma include:

• Heredity, especially a family history of multiple endocrine neoplasia.
• Age over 40 years, since insulinoma is more common among middle-aged people.
• Type 2 diabetes may also be associated with changes in the pancreas and an increased risk of tumor formation.
• Chemical factors such as exposure to certain carcinogens (eg, nitrosamines) may increase the risk of developing pancreatic tumors.
• Problems with glucose regulation may serve as an indirect indicator of predisposition to insulinoma.

Diagnosis of this disease

Diagnosis of insulinoma includes several key aspects, including:

• Main symptoms: characterized by symptoms of hypoglycemia, such as intense hunger, sweating, trembling, tachycardia, dizziness and even loss of consciousness.
• Laboratory tests: measuring blood glucose levels, as well as insulin and C-peptide, to determine if hyperinsulinism is present.
• Radiological examinations: Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the main imaging methods used to determine the size and location of a tumor.
• Other types of diagnostics: Functional tests, such as fasting tests, help confirm the diagnosis by monitoring glucose and insulin levels at various time intervals.
• Differential diagnosis: includes exclusion of other causes of hypoglycemia such as adrenocortical insufficiency, alcohol hypoglycemia and liver disease.

Treatment

Treatment for insulinoma can vary depending on its size, location, and the patient's condition. It includes:

• General treatment: involves lifestyle and dietary changes to control blood sugar levels and reduce the symptoms of hypoglycemia.
• Pharmacological treatment: may include drugs such as diazoxide, which increase blood glucose levels and decrease insulin secretion. Other drugs may be prescribed to manage associated conditions.
• Surgical treatment: is the first choice for insulinoma removal, especially in benign tumors. Laparoscopic resection is indicated for solitary tumors, while surgery for malignant tumors may be more challenging.
• Other types of treatment: include radical chemotherapy or targeted therapy for the treatment of malignant insulinoma.

List of medications used to treat this disease

The main drugs used to treat insulinoma include:

• Diazoxide
• Octareotid
• Sandostatin
• Posmiron
• Glucose (to correct hypoglycemia)

Disease monitoring

Monitoring of insulinoma is important to control the patient's condition and prevent hypoglycemic episodes. Key aspects of monitoring include:

• Control stages: regular consultations with an endocrinologist and examinations to assess insulin and glucose levels.
• Forecast: With early diagnosis and adequate treatment, insulinoma has a good prognosis. However, patients with malignant forms require more careful monitoring.
• Complications: may include severe hypoglycemic conditions that can lead to serious consequences such as seizures or coma.

Age-related features of the disease

Insulinoma may present differently depending on the age group. In children, insulinoma may cause problems with growth and development, while in adults, typical symptoms of hypoglycemia are more common. Older patients may have a more subtle course of the disease and are more likely to have comorbidities such as diabetes and cardiovascular disorders. The effectiveness of diagnosis and treatment may also vary due to the specific physiological characteristics of different age groups.

Questions and Answers

• What is insulinoma? Insulinoma is a tumor of the pancreas that causes excess insulin secretion, leading to hypoglycemia.
• What are the symptoms of insulinoma? The main symptoms include hypoglycemic attacks, which may include sweating, tremors, dizziness and changes in consciousness.
• How is insulinoma diagnosed? Diagnosis includes laboratory tests of glucose and insulin levels, as well as radiological examinations such as CT scan or ultrasound.
• How is insulinoma treated? Treatment can be surgical, pharmacological or combined, depending on the form and age of the patient.
• What is the prognosis for patients with insulinoma? With early detection and adequate treatment, the prognosis for most patients remains favorable.

Advice from Dr. Oleg Korzhikov

Treatment of insulinoma requires a comprehensive approach and careful monitoring. I recommend the following to patients:

• Monitor your blood glucose levels regularly, especially if you have symptoms of hypoglycemia.
• Discuss any changes in your condition with your endocrinologist to adjust your therapy if necessary.
• Eat a diet rich in carbohydrates to avoid sudden drops in blood sugar levels.
• Do not ignore symptoms such as sweating, dizziness or tremors - they may signal critical conditions.
• Contact your doctor if new symptoms occur or if your condition worsens.